Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):1045–1054. doi: 10.1161/ATVBAHA.119.312592

Table 1.

Plasma lipid, glucose, insulin, AST, and bile acid levels of female LDLRKO and FMO3KO/LDLRKO mice maintained on a Western diet for 3 months

Genotype (n) LDLRKO (27) FMO3KO/LDLRKO (16) p-value
Triglyceride (mg/dL) 233 ± 21 197 ± 20 0.26
Total Cholesterol (mg/dL) 1504 ± 39 1292 ± 45 0.002
HDL Cholesterol (mg/dL) 85 ± 3 85 ± 3 0.97
VLDL/IDL/LDL Cholesterol (mg/dL) 1419 ± 39 1206 ± 44 0.0013
Glucose (mg/dL) 229 ± 9 201 ± 9 0.045
Insulin (pg/ml) 605 ± 65 506 ± 37 0.19*
HOMA-IR 10.7 ± 1.2 7.8 ± 0.6 0.03*
AST (U/L) 179 ± 14 170 ± 44 0.83
Bile acids (μM) 11.4 ± 0.7 16.1 ± 5 0.25

Plasma lipids, glucose, and insulin data were collected from 2 independent cohorts of mice. Mice were fasted for 4 hours before blood collection. Values shown are mean ± standard error of each group. Sample sizes for AST and bile acids were 17 and 9 for LDLRKO and FMO3KO/LDLRKO, respectively. Student’s t test was used for data analysis unless noted otherwise.

*

: Unpaired t test with Welch’s correction was used for data analysis due to unequal variances of the two groups.